Cargando…

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda

Detalles Bibliográficos
Autores principales:	Kyosiimire-Lugemwa, J, Pala, P, Miiro, G, Todd, J, Kaleebu, P, Imami, N, Gotch, F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767743/ http://dx.doi.org/10.1186/1742-4690-6-S3-P245

Ejemplares similares

Programmed Death-1(PD-1), a correlate of protection against disease progression in HIV-1 infected long-term non-progressors
por: Kyosiimire-Lugemwa, J
Publicado: (2012)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses
por: Montes, M, et al.
Publicado: (2009)

P20-10. Differences in patterns of Gag-induced immunogenetic pressure occur between clades A and D chronic HIV-1 infection in a Ugandan population
por: Serwanga, J, et al.
Publicado: (2009)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy
por: Culina, S, et al.
Publicado: (2009)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study
por: Vingert, B, et al.
Publicado: (2009)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

P16-12. Relative dominance of Gag-specific cytotoxic T lymphocytes is associated with viral load inversely in HIV-1 clade B' infected Chinese
por: Jia, M, et al.
Publicado: (2009)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

Effect of ART on poly functional profile of CD8 responses to Gag and Nef antigen in HIV infected Indian individuals
por: Mendiratta, Sanjay, et al.
Publicado: (2014)

Comparative proteomics of wild-type and nef-deleted HIV-1 particles
por: Brégnard, Christelle, et al.
Publicado: (2011)

Post-transcriptional control of HIV-1 Gag expression
por: Phalora, Prabhjeet, et al.
Publicado: (2013)

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
por: Meuwissen, PJ, et al.
Publicado: (2011)

Impairment of viral replication capacity by nef alleles from HIV elite controllers
por: Mwimanzi, Philip, et al.
Publicado: (2011)

HIV-1 Nef alters podosomes and promotes the mesenchymal migration in human macrophages
por: Vérollet, Christel, et al.
Publicado: (2013)

Functional characterization of HIV-1 Nef proteins with heterologous membrane targeting signals
por: Geist, Miriam M, et al.
Publicado: (2013)

Early presentation of HIV-1 KF11Gag and KK10Gag protective epitopes facilitate rapid CD8+ T cell activation and killing of virus infected cells
por: Kløverpris, HN, et al.
Publicado: (2012)

Dynamics and frequency of Gag transmitted polymorphisms in Zambia
por: Schaefer, M, et al.
Publicado: (2012)

Potential role of HIV-1 Nef and human M6B in HIV-associated neurological disorders
por: Moetter, Jessica, et al.
Publicado: (2010)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression?
por: Burastero, Samuele, et al.
Publicado: (2006)

Characterisation of a spumavirus Gag protein
por: Goldstone, David C, et al.
Publicado: (2013)

P16-03. Persistence of robust cross-reactive group M consensus T-cell responses in a chronic HIV-1 clade A1 and D-infected Ugandan population
por: Serwanga, JJ, et al.
Publicado: (2009)

HIV-1 Nef compensates for disorganization of the Immunological Synapse by inducing TGN-associated Lck signaling
por: Pan, Xiaoyu, et al.
Publicado: (2011)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

P16-28. The first year: early correlates of long-term HIV progression
por: Chattopadhyay, PK, et al.
Publicado: (2009)

P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
por: Tenzer, S, et al.
Publicado: (2009)

Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans
por: Serwanga, Jennifer, et al.
Publicado: (2009)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P16-04. Cryptic CTL epitopes derived from antisense transcription are frequently recognized in HIV-1 infection
por: Bansal, A, et al.
Publicado: (2009)

Comparable antiviral capacity but favorable in vitro survival of CD8s from elite controllers compared to untreated progressors
por: Shasha, D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1bd9ohan4m9ar21mrbovf3v845